Alternative LDL cholesterol-lowering strategy vs high-intensity statins in atherosclerotic cardiovascular disease: a systematic review and individual patient data meta-analysis
Lee YJ, Hong BK, Yun KH, et al.
JAMA Cardiol. 2024:e243911.
Leggi
Lee YJ, Hong BK, Yun KH, et al.
JAMA Cardiol. 2024:e243911.
Leggi
Kreienkamp RJ, Shields BM, Pollin TI, et al.
Diabetes Care. 2024:dc241565.
Leggi
Harms PP, van Dongen LH, Bennis F, et al.
Diabetes Care. 2024:dc240715.
Leggi
Packer M, Zile MR, Kramer CM, et al.
N Engl J Med. Pub. online 16 Nov 2024.
Leggi
Abdel Jawad M, Spertus JA, Ikeaba U, et al.
JAMA Cardiol. Pub. online 18 Nov 2024.
Leggi
Chimura M, Wang X, Jhund PS, et al.
JAMA Cardiol. 2024:e244613
Leggi
Maghalian M, Mirghafourvand M
BMC Endocr Disord. 2024;24(1):245.
Leggi
Lee B, Man KKC, Wong E, et al.
JAMA Intern Med. Pub. online 18 Nov 2024.
Leggi
Franks PW, Sargent JL
Eur Heart J. 2024:ehae746.
Leggi
Riley DR, Henney A, Anson M, et al.
Diabetes Obes Metab. Pub. online 11 Nov 2024.
Leggi